Elvatron, Seven Pharma, J.I. Cohen, Aceti-Oxigen and Baxter are some of the companies that won contracts to provide medicines and pharmaceutical products to public health institutions in the region last year.
An analysis by the Trade Intelligence Unit of CentralAmericaData provides interesting data on the companies that were favored with contracts to provide pharmaceutical products and medical supplies to the several Ministries of Health and Social Security entities in Central American countries in 2019.
Bayer announced that it plans to expand the operation of its medical device plant and shared service center in Costa Rica in the coming years.
The increase in its presence in Costa Rica is part of the plan to adjust the operation in Central America, the Caribbean and the Andean countries, which the company will implement over the next two years.
In the first half of 2019, purchases of pharmaceutical products made by Central American countries to companies in Mexico totaled $140 million, 7% less than in the same period of 2018.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with graphic"]
The Costa Rican Social Security Fund tenders the supply of blocking nails for tibia, femur and smoke, under the modality of delivery on consignment, directly in each health establishment.
The Ministry of Public Health of the Dominican Republic tenders the supply of high-cost drugs, through the exception mechanism for the exclusivity modality.
The Costa Rican Social Security Fund tenders the supply of effective automated tests for the identification of microorganisms and sensitivity to antibiotics, controls and inputs.
In the first nine months of 2018 in Central America, imports of pharmaceutical products with insulin totaled $23 million, 39% more than the same period in 2017.
Figures from the Commercial Intelligence department of CentralAmericaData: [GRAFICA caption="Click to interact with the graphic"]
J.J. Cohen, Reprico, Labymed and Bioplus Care are some of the companies winning contracts in 2018 to provide medicines to public health institutions in the region.
An analysis of CentralAmericaData's Business Intelligence unit provides data on the companies that were favored last year with contracts to supply pharmaceutical products and medical supplies to the different Ministries of Health and Social Security entities in Central American countries.
Arguing a possible dumping problem, the pharmaceuticals guild in El Salvador opposes a medicine purchase that the Social Security Institute plans to make from a company in China.
The Association of Chemical-Pharmaceutical Industries of El Salvador (Inquifar) reported that the Salvadoran Institute of Social Security (ISSS) seeks to buy medicines and supplies from a company in China, because they expect that the quality of medicine would be put at risk.
Between January and September 2018, imports of pharmaceutical products by Central American countries from Mexico totaled $231 million, 9% more than in the same period in 2017.
Figures from the information system "Commerce between Central America and Mexico", from the Trade Intelligence Area of CentralAmericaData: [GRAFICA caption="Click to interact with graphic"]
Has everything. Ocean views, waterfalls, 20 titled building sites, profits, end of the road privacy but close to everything. Less than an hour to shopping, medical services, beaches, airport. Spring and summer all year, in the 70s – 80s, fresh...
español
4051